Tag : minneapolis

Latest News

FDA approves Blueprint Medicines’ precision therapy for rare form of gastrointestinal cancer

Newsemia
The agency on Thursday approved Ayvakit (avapritinib) for gastrointestinal stromal tumor, or GIST, that harbors a PDGFRa exon 18 mutation. Still, identifying patients could be...
Latest News

Clover Health touts membership growth after restructuring

Newsemia
Clover Health said it added 15,000 new members in the last year, primarily in New Jersey. The news comes after Clover restructured its workforce in...
Latest News

Tandem Diabetes snags FDA approval for interoperable insulin pump software

Newsemia
Tandem Diabetes’ technology will create a new approval pathway for predictive dosing software that can be used with other devices. Source link...
Latest News

FDA to decide on Spectrum Pharmaceuticals’ neutropenia drug by Oct. 2020

Newsemia
Spectrum said the FDA had accepted its application for Rolontis, which had shown non-inferiority to Amgen’s Neulasta in Phase III testing. However, oncologists expressed mixed...
Latest News

Alphabet subsidiary partners with Emory Healthcare

Newsemia
The partnership adds to Verily’s growing work in value-based reimbursement. Source link...
Latest News

Make-A-Wish grants more life-changing wishes for children with cancer thanks to Bristol-Myers Squibb

Newsemia
Charitable donations from Bristol-Myers Squibb have enabled more than 200 wishes in just 3 years and through 2019, the company has provided more than $3...
Latest News

Telehealth’s emergence as the initial gateway into behavioral health services

Newsemia
While in-person visits with mental health providers won’t go away anytime soon, behavioral telehealth is expected to surge, as younger patients seek convenient ways to...
Latest News

Los Angeles startup uses AI to reduce unnecessary spine surgeries

Newsemia
Newly formed Theseus AI plans to reduce unnecessary back surgery referrals by providing more objective MRI data to physicians. Source link...
Latest News

Battling bullets from the operating room to the community

Newsemia
In St. Louis, Missouri, Dr. Laurie Punch plunged her gloved hands into Sidney Taylor’s open […] Source link...
Latest News

For investors, digital health data outweighs algorithms

Newsemia
Investors at the SoCalbio Digital Health Conference said they look for good data first when investing in digital health companies. Source link...
Latest News

Website errors raise calls for Medicare to Be flexible with seniors’ enrollment

Newsemia
Beneficiaries are going to be able to change plans next year because of misinformation through the website for Medicare enrollment although officials provided few details....
Latest News

What will it take to improve recruitment for clinical trials?

Newsemia
Whether clinical trial travel requires a short rideshare trip or a flight halfway across the world, the key to keeping participants enrolled and engaged is...
Latest News

Angion’s kidney therapy advances

Newsemia
The 28-patient study showed that Angion’s drug improved kidney function, based on patients’ estimated glomerular filtration rate (eGFR), a key renal function metric. Source link...
Latest News

Why Google is buying Fitbit

Newsemia
We spoke to investors and analysts to figure out why Google is buying Fitbit, a company that hasn’t made much of a dent in the...
Latest News

Amgen to stop selling Repatha at higher list price, offer low-priced option exclusively

Newsemia
The biotech company had kept the drug available at the higher list price in order to give payers and pharmacy benefit managers time to adjust...
Latest News

Download the HLTH app to maximize your networking game

Newsemia
In its second year, HLTH is offering a smorgasbord of programs designed to facilitate networking at its conference at the MGM Grand in Las Vegas October...
Latest News

Get ready for the second annual HLTH conference

Newsemia
MedCity’s patient engagement conference ENGAGE will be part of the HLTH conference for the first time this year. ENGAGE at HLTH on October 28 will feature innovators from...
Latest News

UCB psoriasis drug beats J&J’s second top-selling product in Phase III study

Newsemia
Results of the BE VIVID study showed that UCB’s bimekizumab showed a statistically significant improvement in skin clearance compared with J&J’s Stelara and placebo. Source...
Latest News

Whistleblower alleges Medicare fraud at iconic Seattle-based health plan

Newsemia
The Justice Department has thus far declined to take over the case, which alleges wrongdoing by Seattle-based nonprofit health plan, Group Health, but said in...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy